U.S. Food Stock News

Alkermes plc recently reported that fourth‑quarter 2025 revenue slipped to US$384.55 million, with net income and earnings per share also lower year over year, while the Board confirmed CEO Richard Pops will retire in July 2026 and current COO Blair Jackson will assume the CEO role in August 2026. Alongside these results, Alkermes advanced its orexin agonist ALKS 2680 into Phase 3 trials for narcolepsy type 1, highlighting how its neuroscience pipeline is becoming increasingly central to the...

What ArriVent BioPharma’s Recent Moves Mean For Investors ArriVent BioPharma (AVBP) has been drawing attention after recent share price swings, including a 7.2% decline over the past day alongside a gain of about 7% over the past month. For a clinical stage company with no reported revenue and a net loss of US$166.308 million, those moves highlight how quickly sentiment can shift as investors weigh its cancer drug pipeline and collaborations. See our latest analysis for ArriVent...

Certara recently highlighted that its Simcyp physiologically-based pharmacokinetic modeling was accepted by the U.S. FDA in place of multiple clinical pharmacology studies to support the new drug application for asciminib (Scemblix®), an allosteric BCR::ABL1 inhibitor for Chronic Myeloid Leukemia. This decade-long modeling effort, which replaced at least ten dedicated clinical studies and informed dosing and drug-interaction decisions, underscores how biosimulation can cut development costs...

In early March 2026, MongoDB announced the hiring of Erica Volini as Chief Customer Officer, the planned departures of its President of Field Operations and Chief Revenue Officer, and issued new guidance for fiscal 2027 calling for revenues of US$2.86 billion to US$2.90 billion alongside continued operating and per‑share losses. The company also reported full‑year 2026 revenue of US$2,463.80 million and a reduced net loss of US$71.15 million, highlighting ongoing scale gains even as...

EMCOR Group, Inc. recently reported its fourth-quarter 2025 results, with sales rising to US$4,513.12 million and net income reaching US$434.61 million, alongside full-year 2025 sales of US$16.99 billion and net income of US$1.27 billion. The company also issued 2026 guidance calling for revenues between US$17.75 billion and US$18.50 billion and diluted EPS of US$27.25 to US$29.25, underlining management’s confidence after a year of higher earnings per share from continuing operations. Now...

In early March 2026, Northrop Grumman gained attention as geopolitical tensions escalated with U.S. and Israeli strikes on Iranian nuclear and military sites, while the company continued to advance long-term defense programs such as the B-21 Raider, Sentinel ICBM, and the Deep Space Advanced Radar Capability. At the same time, evolving U.S. rules on Chinese-origin rare earths and new domestic processing capacity are reshaping supply chains that underpin Northrop Grumman’s future platforms...

Azenta (AZTA) has drawn attention after recent share price pressure, with the stock down about 27% year to date and roughly 44% over the past year. This has prompted investors to reassess its fundamentals. See our latest analysis for Azenta. The recent pressure on Azenta’s share price, including a 1-day share price return of negative 1.98% and a 30-day share price return of negative 15.39%, sits on top of a 1-year total shareholder return of negative 44.37%. This signals that momentum has...

If you are wondering whether Ellington Financial is offering real value at today's price, or if you would be overpaying for its income stream and assets, this article walks through that question step by step. The stock last closed at US$12.03, with returns of a 3.1% decline over 7 days, a 7.5% decline over 30 days, a 12.1% decline year to date and a 0.4% decline over 1 year. The 3 year and 5 year returns stand at 54.0% and 33.0% respectively. Recent news coverage around Ellington Financial...

What triggered fresh interest in Xeris Biopharma Holdings (XERS)? Xeris Biopharma Holdings (XERS) has drawn fresh attention after reporting fourth quarter and full year 2025 results that moved from loss to profit, paired with new 2026 revenue guidance and a US$40.7 million shelf registration filing. See our latest analysis for Xeris Biopharma Holdings. Despite Xeris Biopharma Holdings posting improved earnings and setting 2026 revenue guidance, recent share price returns have been weak, with...

What recent performance says about Kilroy Realty Kilroy Realty (KRC) has drawn investor attention after a recent 3.7% daily share price decline, capping a month return of about 14.8% lower and a past 3 months move of roughly 26.3% lower. See our latest analysis for Kilroy Realty. At a share price of US$29.81, Kilroy Realty’s recent 30-day share price return of 14.8% lower and year to date return of 21.6% lower suggest momentum has been fading, even though the 3-year total shareholder return...

HF Sinclair recently reported strong fourth-quarter adjusted earnings that exceeded analyst expectations, announced Vivek Garg as acting CFO, and confirmed CEO Tim Go’s voluntary leave of absence amid a review of the company’s disclosure process, with Franklin Myers stepping in as temporary CEO. At the same time, Sinclair Oil’s Fueling Folds of Honor campaign raised over US$1,000,000 for scholarships to families of fallen or disabled military and first responders, underlining HF Sinclair’s...

Why Cellebrite DI (NasdaqGS:CLBT) Is On Investor Radars Now Cellebrite DI (NasdaqGS:CLBT) has drawn investor attention recently after a period of mixed share performance, with gains over the past month but negative returns over the past 3 months and year to date. Against this backdrop, the company’s current valuation metrics and fundamentals, including revenue of US$475.7 million and net income of US$77.8 million, are in focus for investors assessing the durability of its digital...

In early March 2026, Air Products and Chemicals reported that it was in advanced talks with Yara International on major hydrogen and ammonia projects in the U.S. and Saudi Arabia, while reaffirming its 2026 adjusted EPS guidance despite helium-related pressures. The planned Louisiana complex, estimated at about US$8.00–US$9.00 billion and targeting completion by 2030, together with expected renewable ammonia agreements linked to the NEOM Green Hydrogen Project from 2026, underscores how...

MarketAxess Holdings Inc. recently appointed William Quan as Chief Technology Officer, tasking him with modernizing its global technology platforms and embedding AI and advanced data capabilities across the business. By bringing in a leader with deep experience in electronic trading and AI-driven platforms from firms like Amazon Web Services, J.P. Morgan, and Deutsche Bank, MarketAxess is signaling a stronger push to enhance its bond-trading technology and product innovation. With William...

In recent days, analysts have raised their expectations for Casey’s General Stores ahead of its March 9, 2026 earnings release, highlighting strong sales trends, prepared food innovation, and an expanding store base that is estimated to reach 2,952 locations. Heightened social media discussion, including speculation about a potential stock split and enthusiasm around management’s expansion efforts, underscores how sentiment has intensified as investors focus on forecasts for higher earnings...

APA Corporation recently dually listed its common stock on the newly launched Nasdaq Texas exchange while maintaining its primary Nasdaq listing, and also reported 2025 results with full-year revenue of US$9.22 billion and net income of US$1.43 billion. The combination of steady 2025 production volumes and the new Texas-focused listing highlights APA’s effort to deepen local investor access while underscoring its scale as a global energy producer. We’ll now examine how the dual Nasdaq Texas...

Construction Partners (ROAD) shares recently faced pressure as geopolitical tensions in the Middle East pushed oil prices higher, weighing on construction related names and raising fresh questions for investors about costs, inflation and project economics. See our latest analysis for Construction Partners. The recent 6% one day share price decline and 12.1% 7 day share price pullback sit against a different bigger picture, with a 90 day share price return of 13.3% and a 1 year total...

In February 2026, Marqeta, Inc. reported fourth-quarter 2025 sales of US$172.11 million with sharply reduced net losses, issued 2026 guidance calling for double-digit net revenue and gross profit growth, and filed a US$106.08 million shelf registration for 25,935,338 Class A shares tied to an employee stock plan. This combination of improving financial results, clearer growth expectations, and a sizeable employee share offering highlights how Marqeta is balancing expansion with capital and...

Avantor stock performance snapshot Avantor (AVTR) has drawn attention after recent share price weakness, with the stock closing at US$8.17. For investors, the key questions now center on how current fundamentals align with this lower trading level. See our latest analysis for Avantor. The recent 1 day share price return of 4.11% and 7 day return of 9.72% add to a 30 day share price decline of 27.44%. The 1 year total shareholder return of 53.31% and 5 year total shareholder return of 71.17%...

In early 2026, Genuine Parts Company announced plans to separate by the first quarter of 2027 into two independent, publicly traded businesses: Global Automotive and Global Industrial, each with distinct operational and capital allocation priorities. The separation is designed to give investors clearer exposure to Genuine Parts’ auto parts distribution and industrial distribution operations, which will be pursuing different growth, efficiency, and acquisition paths. Next, we’ll examine how...

In recent days, investor concerns about regional banks’ exposure to the opaque private credit market have weighed on The Bancorp, amid broader sector jitters following defaults and loan write-offs in that space. These worries come on top of earlier pressure from weaker quarterly results and a shrinking net interest margin, even as The Bancorp has built a niche in specialized fintech-focused banking and lending solutions. Next, we’ll examine how heightened worries about private credit...

In late February 2026, Starwood Property Trust, Inc. announced that its board had authorized a one-year share repurchase program of up to US$400 million, to be funded entirely from existing cash. This buyback authorization, following the company’s full-year 2025 results, signals a clear willingness to return capital while balancing earnings, leverage, and portfolio risk considerations. We’ll now examine how this sizable cash-funded buyback authorization may influence Starwood Property...

Bilibili (BILI) just reported its fourth quarter and full year 2025 earnings, marking its first annual net profit after earlier losses. The results were closely tied to advertising, user growth and AI driven monetization. See our latest analysis for Bilibili. Bilibili’s recent earnings milestone has arrived alongside a weaker share price patch, with a 30 day share price return of a 21.76% decline and a 1 year total shareholder return of 2.37%. This suggests that shorter term momentum has...

In February 2026, Xylem Inc. announced that its Board of Directors had approved a new share repurchase program, authorizing the company to buy back up to US$1.50 billion of its own stock with no expiration date. This move follows the completion of a prior authorization under which Xylem repurchased 5,200,000 shares for US$321.90 million, highlighting an ongoing preference for returning capital to shareholders alongside reinvestment in the business. We’ll now explore how this sizable,...